Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mary Pritzlaff"'
Autor:
Linda S. Robinson, Ashley Hendrix, Xian-Jin Xie, Jingsheng Yan, Sara Pirzadeh-Miller, Mary Pritzlaff, Parker Read, Sarah Pass, David Euhus, Theodora S. Ross
Publikováno v:
EBioMedicine, Vol 2, Iss 11, Pp 1827-1833 (2015)
Background: The US Preventative Service Task Force recommends that physicians perform a genetic risk assessment to identify women at risk for BRCA1/2 mutations associated with hereditary breast and ovarian cancer (HBOC) syndrome. However, outcomes da
Externí odkaz:
https://doaj.org/article/a8538bdf7e24433eb2dcded4c125fc8e
Publikováno v:
JCO Precis Oncol
PURPOSE Guidelines for prostate cancer (PCA) germline testing (GT) have expanded, with impact on clinical management and hereditary cancer assessment. African American (AA) men have lower engagement in GT, with concern for widening disparities in gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3abecec816ba341e09dec7a85b96f71d
https://europepmc.org/articles/PMC9200399/
https://europepmc.org/articles/PMC9200399/
Autor:
Kyle Allen, Jill S. Dolinsky, Carolyn Horton, Mary Helen Black, Mary Pritzlaff, Holly LaDuca, Jessica Profato
Publikováno v:
Cancer Research. 80:P6-08
Impact of Multigene Panel Testing on Medical Management: Preliminary results of a pre- and post-test clinician survey Identification of individuals with germline variants in cancer predisposition genes has risk management and therapeutic implications
Publikováno v:
Journal of Clinical Oncology. 40:10502-10502
10502 Background: Germline testing (GT) for prostate cancer (PCA) is central to metastatic disease management, PCA screening strategies, and hereditary cancer assessment. African American (AA) males have a higher burden of PCA, yet have lower engagem
Autor:
Parker Read, Sarah Pass, Sara Pirzadeh-Miller, Jingsheng Yan, David M. Euhus, Ashley Hendrix, Xian Jin Xie, Theodora S. Ross, Linda S. Robinson, Mary Pritzlaff
Publikováno v:
EBioMedicine, Vol 2, Iss 11, Pp 1827-1833 (2015)
EBioMedicine
EBioMedicine
Background The US Preventative Service Task Force recommends that physicians perform a genetic risk assessment to identify women at risk for BRCA1/2 mutations associated with hereditary breast and ovarian cancer (HBOC) syndrome. However, outcomes dat
Publikováno v:
Journal of Urology. 199
Autor:
Theodora S. Ross, Sara Pirzadeh-Miller, David M. Euhus, Mary Pritzlaff, Linda S. Robinson, Arielle Yorczyk, Tirun Lin
Publikováno v:
Journal of Genetic Counseling. 23:1034-1044
CancerGene Connect (CGC) is a web-based program that combines the collection of family and medical history, cancer risk assessment, psychosocial assessment, report templates, a result tracking system, and a patient follow up system. The performance o
Autor:
Sara Pirzadeh, Mary Pritzlaff
Publikováno v:
Community Oncology. 7:315-320
Autor:
Shuwei Li, Jill S. Dolinsky, Hermela Shimelis, Fergus J. Couch, Rachel McFarland, Elizabeth C. Chao, David E. Goldgar, Summerour Pia, LaDuca Holly, Mary Pritzlaff
Publikováno v:
Cancer Research. 77:3406-3406
While the population-based risk for breast cancer in males remains relatively low (1:1000), inherited predisposition can significantly raise this to as high as 10%, in men who carry a mutation in the BRCA2 gene. Lifetime breast cancer risks of 1-2% h
Publikováno v:
Cancer Research. 76:PD7-06
INTRODUCTION: The role of BRCA2 and BRCA1 in male breast cancer is well established, however, there is limited data regarding the role of other genes in male breast cancer. The aim of this study was to assess the clinical characteristics and genetic